Weber JS - Search Results

1

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.

Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. Among authors: weber js. J Natl Cancer Inst. 1994 Aug 3;86(15):1159-66. doi: 10.1093/jnci/86.15.1159. J Natl Cancer Inst. 1994. PMID: 8028037

2

Clinical application of IL6 in cancer therapy.

Mulé JJ, Marcus SG, Yang JC, Weber JS, Rosenberg SA. Mulé JJ, et al. Among authors: weber js. Res Immunol. 1992 Sep;143(7):777-9. doi: 10.1016/0923-2494(92)80023-e. Res Immunol. 1992. PMID: 1439156 Clinical Trial. No abstract available.

3

Phenotypic characterization of murine tumor-infiltrating T lymphocytes.

Karpati RM, Banks SM, Malissen B, Rosenberg SA, Sheard MA, Weber JS, Hodes RJ. Karpati RM, et al. Among authors: weber js. J Immunol. 1991 Mar 15;146(6):2043-51. J Immunol. 1991. PMID: 1672340

4

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. Weber JS, et al. J Clin Oncol. 1992 Jan;10(1):33-40. doi: 10.1200/JCO.1992.10.1.33. J Clin Oncol. 1992. PMID: 1727923

5

Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes.

Weber JS, Rosenberg SA. Weber JS, et al. J Natl Cancer Inst. 1990 May 2;82(9):755-61. doi: 10.1093/jnci/82.9.755. J Natl Cancer Inst. 1990. PMID: 2109092

6

In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes.

Fox BA, Spiess PJ, Kasid A, Puri R, Mulé JJ, Weber JS, Rosenberg SA. Fox BA, et al. Among authors: weber js. J Biol Response Mod. 1990 Oct;9(5):499-511. J Biol Response Mod. 1990. PMID: 2174966

7

Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.

Weber JS, Rosenberg SA. Weber JS, et al. Cancer Res. 1988 Oct 15;48(20):5818-24. Cancer Res. 1988. PMID: 3139284

8

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.

Weber JS, Jay G, Tanaka K, Rosenberg SA. Weber JS, et al. J Exp Med. 1987 Dec 1;166(6):1716-33. doi: 10.1084/jem.166.6.1716. J Exp Med. 1987. PMID: 3500265 Free PMC article.

9

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. Weber J, et al. Cancer Res. 1994 Apr 1;54(7):1766-71. Cancer Res. 1994. PMID: 7511051

10

Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide.

Salgaller ML, Weber JS, Koenig S, Yannelli JR, Rosenberg SA. Salgaller ML, et al. Among authors: weber js. Cancer Immunol Immunother. 1994 Aug;39(2):105-16. doi: 10.1007/BF01525316. Cancer Immunol Immunother. 1994. PMID: 7519125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters